EverSource Wealth Advisors LLC Has $185,000 Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

EverSource Wealth Advisors LLC grew its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 12.3% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 311 shares of the biotechnology company’s stock after buying an additional 34 shares during the period. EverSource Wealth Advisors LLC’s holdings in Axon Enterprise were worth $185,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in AXON. Asset Dedication LLC increased its position in shares of Axon Enterprise by 11.3% in the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after buying an additional 18 shares in the last quarter. Bleakley Financial Group LLC grew its stake in Axon Enterprise by 1.3% in the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock valued at $908,000 after acquiring an additional 20 shares during the period. Venturi Wealth Management LLC increased its holdings in shares of Axon Enterprise by 2.7% in the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock worth $477,000 after acquiring an additional 21 shares in the last quarter. Insigneo Advisory Services LLC raised its position in shares of Axon Enterprise by 1.4% during the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after purchasing an additional 22 shares during the period. Finally, Menard Financial Group LLC lifted its holdings in shares of Axon Enterprise by 0.8% during the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after purchasing an additional 24 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 1,370 shares of the company’s stock in a transaction that occurred on Tuesday, December 17th. The stock was sold at an average price of $639.14, for a total value of $875,621.80. Following the sale, the insider now owns 125,950 shares in the company, valued at $80,499,683. This represents a 1.08 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, President Joshua Isner sold 1,291 shares of the firm’s stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total value of $829,377.13. Following the completion of the sale, the president now directly owns 181,892 shares of the company’s stock, valued at approximately $116,852,877.56. The trade was a 0.70 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 4,146 shares of company stock valued at $2,623,157. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Stock Performance

Shares of AXON opened at $556.26 on Monday. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The firm has a fifty day simple moving average of $593.42 and a 200 day simple moving average of $536.68. The stock has a market capitalization of $42.62 billion, a price-to-earnings ratio of 143.74, a PEG ratio of 5.17 and a beta of 1.12. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Wall Street Analysts Forecast Growth

Several analysts have commented on AXON shares. Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. Needham & Company LLC reissued a “buy” rating and set a $600.00 price objective on shares of Axon Enterprise in a research report on Wednesday, February 26th. Barclays reaffirmed a “hold” rating on shares of Axon Enterprise in a research report on Monday, March 10th. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Finally, The Goldman Sachs Group upped their price objective on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $604.67.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.